Copolymer-1 (Cop-1) improves neurological recovery after middle cerebral artery occlusion in rats

Neuroscience Letters

Volumn 425, Issue 2, 2007, Pages 110-113

  Ibarra, Antonio ^a   Avendaño, Héctor ^a   Cruz, Yolanda ^a  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

Author keywords

Copaxone; Focal cerebral ischemia; Glatiramer acetate; Middle cerebral artery occlusion; Neuroprotection; Protective autoimmunity

Indexed keywords

GLATIRAMER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INFARCTION; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; HISTOPATHOLOGY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROPATHOLOGY; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; STROKE; TH2 CELL;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BRAIN; BRAIN ISCHEMIA; CEREBRAL INFARCTION; CYTOKINES; ENCEPHALITIS; IMMUNOLOGIC FACTORS; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; NERVE GROWTH FACTORS; NEUROPROTECTIVE AGENTS; PEPTIDES; RATS; RATS, SPRAGUE-DAWLEY; RECOVERY OF FUNCTION; TH2 CELLS; TREATMENT OUTCOME;

EID: 34548778588     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2007.08.038     Document Type: Article

References (24)

1. Aharoni R., Eilam R., Domev H., Labunskay G., Sela M., and Arnon R. The immunomodulator glatiramer acetate augments the expression of neurotrophic factors in brains of experimental autoimmune encephalomyelitis mice. Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 19045-19050
2. Aharoni R., Kayhan B., Eilam R., Sela M., and Arnon R. Glatiramer acetate-specific T cells in the brain express T helper 2/3 cytokines and brain-derived neurotrophic factor in situ. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 14157-14162
3. Angelov D.N., Waibel S., Guntinas-Lichius O., Lenzen M., Neiss W.F., Tomov T.L., Yoles E., Kipnis J., Schori H., Reuter A., Ludolph A., and Schwartz M. Therapeutic vaccine for acute and chronic motor neuron diseases: implications for amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. 100 (2003) 4790-4795
4. Arnon R., and Aharoni R. Mechanism of action of glatiramer acetate in multiple sclerosis and its potential for the development of new applications. Proc. Natl. Acad. Sci. U.S.A. 101 Suppl. 2 (2004) 14593-14598
5. Arnon R., and Sela M. Immunomodulation by the copolymer glatiramer acetate. J. Mol. Recogn. 16 (2003) 412-421
6. Arnon R., Sela M., and Teitelbaum D. New insights into the mechanism of action of copolymer 1 in experimental allergic encephalomyelitis and multiple sclerosis. J. Neurol. 243 (1996) S8-S13
7. Avidan H., Kipnis J., Butovsky O., Caspi R.R., and Schwartz M. Vaccination with autoantigen protects against aggregated beta-amyloid and glutamate toxicity by controlling microglia: effect of CD4+CD25+T cells. Eur. J. Immunol. 34 (2004) 3434-3445
8. Bakalash S., Kessler A., Mizrahi T., Nussenblatt R., and Schwartz M. Antigenic specificity of immunoprotective therapeutic vaccination for glaucoma. Invest. Ophthalmol. Vis. Sci. 44 (2003) 3374-3381
9. Benner E.J., Mosley R.L., Destache C.J., Lewis T.B., Jackson-Lewis V., Gorantla S., Nemachek C., Green S.R., Przedborski S., and Gendelman H.E. Therapeutic immunization protects dopaminergic neurons in a mouse model of Parkinson's disease. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 9435-9440
10. Butovsky O., Koronyo-Hamaoui M., Kunis G., Ophir E., Landa G., Cohen H., and Schwartz M. Glatiramer acetate fights against Alzheimer's disease by inducing dendritic-like microglia expressing insulin-like growth factor 1. Proc. Natl. Acad. Sci. U.S.A. 103 (2006) 11784-11789
11. Castillo J. Physiopathology of cerebral ischemia. Rev. Neurol. 30 (2000) 459-464
12. Hendrix S., and Nitsch R. The role of T helper cells in neuroprotection and regeneration. J. Neuroimmunol. 184 (2007) 100-112
13. Kipnis J., Mizrahi T., Yoles E., Ben-Nun A., and Schwartz M. Myelin specific Th1 cells are necessary for post-traumatic protective autoimmunity. J. Neuroimmunol. 130 (2002) 78-85
14. Kipnis J., Nevo U., Panikashvili D., Alexandrovich A., Yoles E., Akselrod S., Shohami E., and Schwartz M. Therapeutic vaccination for closed head injury. J. Neurotrauma 20 (2003) 559-569
15. Kipnis J., and Schwartz M. Dual action of glatiramer acetate (Cop-1) in the treatment of CNS autoimmune and neurodegenerative disorders. Trends Mol. Med. 8 (2002) 319-323
16. Kipnis J., Yoles E., Porat Z., Cohen A., Mor F., Sela M., Cohen I.R., and Schwartz M. T cell immunity to copolymer 1 confers neuroprotection on the damaged optic nerve: possible therapy for optic neuropathies. Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 7446-7451
17. Kuchroo V.K., Sobel R.A., Laning J.C., Martin C.A., Greenfield E., Dorf M.E., and Lees M.B. Experimental allergic encephalomyelitis mediated by cloned T cells specific for a synthetic peptide of myelin proteolipid protein. Fine specificity and T cell receptor V beta usage. J. Immunol. 148 (1992) 3776-3782
18. Laurie C., Reynolds A., Coskun O., Bowman E., Gendelman H.E., and Mosley R.L. CD4+ T cells from copolymer-1 immunized mice protect dopaminergic neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease. J. Neuroimmunol. 183 (2007) 60-68
19. Longa E.Z., Weinstein P.R., Carlson S., and Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 20 (1989) 84-91
20. Pannu R., Barbosa E., Singh A.K., and Singh I. Attenuation of acute inflammatory response by atorvastatin after spinal cord injury in rats. J. Neurosci. Res. 79 (2005) 340-350
21. Schori H., Kipnis J., Yoles E., WoldeMussie E., Ruiz G., Wheeler L.A., and Schwartz M. Vaccination for protection of retinal ganglion cells against death from glutamate cytotoxicity and ocular hypertension: implications for glaucoma. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 3398-3403
22. Teitelbaum D., Aharoni R., Arnon R., and Sela M. Specific inhibition of the T-cell response to myelin basic protein by the synthetic copolymer Cop 1. Proc. Natl. Acad. Sci. U.S.A. 85 (1988) 9724-9728
23. Teitelbaum D., Meshorer A., Hirshfeld T., Arnon R., and Sela M. Suppression of experimental allergic encephalomyelitis by a synthetic polypeptide. Eur. J. Immunol. 1 (1971) 242-248
24. Webb C., Teitelbaum D., Herz A., Arnon R., and Sela M. Molecular requirements involved in suppression of EAE by synthetic basic copolymers of amino acids. Immunochemistry 13 (1976) 333-337